Orphan Drugs & Rare Diseases- Innovative Strategies for Getting Orphan Drugs to Where They Are Needed

-

The call to treat rare diseases has become increasingly greater around the world than ever before. Supportive organisations including patient groups, national health authorities, health trusts, academia, HTAs, pharmaceutical and biotechnical companies are now progressively growing in numbers and sophistication in their approaches to medicinal care for those with rare and ultra-rare diseases.

SMi’s Orphan Drugs & Rare Diseases conference will present briefings from key opinion leaders, those with hands-on experience of regulating new drug discoveries, companies that have already developed advanced orphan drugs & successfully been granted orphan medicine status and selected experts in the field. Our expert speakers will offer unique insights into cutting-edge international developments taking place in: expanding the reach of medicine to previously untreatable and unreachable patients with rare diseases; different regulatory and policy environments; new drug discoveries; innovative business strategies & funding & financing models, and the importance of partnerships with patient groups and those at the point-of-care.

Key benefits of attending:

• Learn about health technology assessment protocols and market access in the EU and globally
• Network with key regulators of orphan medicines and policy makers for national rare disease treatment
• Discover successful funding, financing and economic models for orphan drug development and translational research
• Analyse industry case studies showing how R&D and market access costs can be reduced
• Understand the latest developments in ultra-rare diseases studies and new medicines for them
• Explore how organisations are merging research, resources and expertise in the race to cure rare diseases

Hear keynote addresses from:
• Dr. Edmund Jessop, Medical Advisor, National Commissioning Group for Highly Specialised Services, NHS
• Josie Godfrey, Head of Policy and Coordination, AGNSS

• Stephen Nutt, Executive Officer, Rare Disease UK

• Carlos R. Camozzi, MD, PhD, MBA, Vice President, Chief Medical Officer, uniQure B.V.

• Marisa Jaconi, Vice-Director and Founder, Swiss Institute of Cell Therapies (SICT)

• Samantha Parker, Director of External Affairs and Rare Disease Partnerships, Orphan Europe


Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

8 Oct 2012

UPCOMING FEATURED EVENTS 1 2 Next 
ELRIG Drug Discovery 20142 Sep 2014 Read
Neuroscience 201415 Nov 2014 Read
ASCB 20146 Dec 2014 Read
SLAS20157 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read
ESCMID European Society of Clinical Microbiology and Infectious Diseases25 Apr 2015 Read
AACC (American Association for Clinical Chemistry)26 Jul 2015 Read


ALL UPCOMING EVENTS
1 2 3 Next 
BIO15 Jun 2015 Read
HPLC21 Jun 2015 Read
ISSCR (International Society for Stem Cell Research)24 Jun 2015 Read
Microscience29 Jun 2015 Read
AACC (American Association for Clinical Chemistry)26 Jul 2015 Read
Microscopy & Microanalysis2 Aug 2015 Read
WMIC 20152 Sep 2015 Read
ASHG 20156 Oct 2015 Read
Neuroscience 201517 Oct 2015 Read
AAPS 201525 Oct 2015 Read
Medica 201516 Nov 2015 Read
ASCB 201512 Dec 2015 Read